Efficacy and safety of cosibelimab in advanced cutaneous squamous cell carcinoma: Results from a Pivotal Open-label Study with a median follow-up of ≥2 years
Cosibelimab demonstrated robust and durable ORRs with increasing CR rates in advanced CSCC and low rates of severe immune-related adverse events.
Authors
- James Oliviero (ORCID: https://orcid.org/0009-0009-9857-1189)
- Charlée Nardin
- Daniel R Malan
- Margaret McGrath (ORCID: https://orcid.org/0000-0001-7267-853X)
- María del Carmen Álamo de la Gala
- Ricardo Yayá (ORCID: https://orcid.org/0000-0002-8154-889X)
- Andrea Tazbirkova
- Marie Beylot-Barry
- Rahul Ladwa
- Henri Montaudié (ORCID: https://orcid.org/0000-0002-0528-4829)
- Emily S. Ruiz (ORCID: https://orcid.org/0000-0001-5824-2721)
- Philip R. Clingan
- Eva Muñoz‐Couselo (ORCID: https://orcid.org/0000-0001-7556-7608)
- Daniel Brungs (ORCID: https://orcid.org/0000-0002-8154-6966)
- Samuel Fourie (ORCID: https://orcid.org/0000-0003-3759-3201)
- Miguel‐Ángel Berciano‐Guerrero (ORCID: https://orcid.org/0000-0002-5437-5196)
- Wm. Gray
- Hong Shue
- J. Charles (ORCID: https://orcid.org/0000-0003-4667-6009)
- Gaelle Quereux (ORCID: https://orcid.org/0000-0002-1739-1701)
- Dean Harris (ORCID: https://orcid.org/0000-0002-7198-6319)
- Stéphane Dalle
- Lauren Neighbours Wilcoxen
Institutions
- Hebron University (PS)
- Brigham and Women's Hospital (US)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- University of the Sunshine Coast (AU)
- University of Wollongong (AU)
- Greenslopes Private Hospital (AU)
- Wollongong Hospital (AU)
- Princess Alexandra Hospital (AU)
- Christchurch Hospital (NZ)
- Centre Hospitalier Universitaire de Nice (FR)
- Centre Hospitalier Universitaire de Besançon (FR)
- Hospital Universitario Virgen Macarena (ES)
- Hospices Civils de Lyon (FR)
- Sunshine Coast University Hospital (AU)
- Fundación Instituto Valenciano de Oncología (ES)
- Port Elizabeth Provincial Hospital (ZA)
- Flinders Private Hospital (AU)
- Hôpital Saint-André (FR)
- Hôpital Lyon Sud (FR)
- Gallipoli Medical Research Foundation (AU)
- Centre de Recherche en Cancérologie de Lyon (FR)
- Vall d'Hebron Hospital Universitari (ES)
- Centre d'Investigation Clinique de Nantes (FR)
- Check Point (Israel) (IL)
- Bronberg Observatory (ZA)
- Instituto de Investigación Biomédica de Málaga (ES)
- Université Grenoble Alpes (FR)
- HCL Technologies (India) (IN)
- Nantes Université (FR)
Publication Details
- Journal
- Journal of the American Academy of Dermatology
- Published
- 2025-09-30
- DOI
- https://doi.org/10.1016/j.jaad.2025.09.009
- Citations
- 1
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35